EC0.1ml
Vaccineexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
1
Earliest trial started Apr 17, 2023 (NCT05746611)
Timeline
No events for the selected filters.
Indications
Approved for
Studied for
Mechanism of action
- Mycobacterium tuberculosisImmunity, active
Mycobacterium tuberculosis immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05746611 | Phase 4 | Apr 17, 2023 | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd., Government of China |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | For profit | 1 | 1 | 1 | 2023 |
| Government of China | Government | 1 | 0 | 1 | 2023 |
2 organizations
Page 1 / 1